Covalent modification and site-directed mutagenesis of an active site tryptophan of human prostatic acid phosphatase

• Autorzy: Zhang Z. , Ostanin K. , Van Etten R.L.
• Języki publikacji: EN

Abstrakty

EN

Because tryptophans are found as part of the phosphate binding sites in a number of proteins, human prostatic acid phosphatase (hPAP) was examined for the presence and the role of essential tryptophan residues. The pH dependence of the intrinsic fluorescence of hPAP resembled the kinetic pH dependence. Chemical modification by N-bromosuccinimide (NBS) resulted in an inactivation of the enzyme and produced a characteristic reduction of the protein absorbance at 280 nm. Two tryptophans per subunit were modified, and this was accompanied by an apparently complete loss of enzymatic activity. In the presence of the competitive inhibitor L-(+)-tartrate, the loss of enzyme activity was significantly reduced as compared to the rate of tryptophan modification. After labeling the protein with 2,4-dinitrophenylsulfenyl chloride (DNPS-Cl), two tryptic peptides containing DNPS-labeled tryptophans were isolated and the sequences were identified by amino acid sequence analysis and mass spectroscopy. One peptide corresponded to residues 172-176, and included Trp174. The other corresponded to the C-terminal sequence, including Trp336. It was concluded that Trp174 was at the active site of the human enzyme because it was protected by the competitive inhibitor tartrate in the DNPS-Cl modification studies. This is also consistent with the location of a homologous residue in the structure of the rat enzyme. Using site-directed mutagenesis, Trp174 was replaced by Phe or Leu. Both mutants showed altered kinetic properties, including lower Km values with several aromatic substrates, and also exhibited reduced stability towards urea denaturation.

Słowa kluczowe

EN

substrate binding; N-bromosuccinimide; covalent modification; dinitrophenylsulphenyl chloride; man; prostatic acid phosphatase; mutagenesis; tryptophan

• Wydawca: -
• Czasopismo: Acta Biochimica Polonica
• Rocznik: 1997
• Tom: 44
• Numer: 4
• Opis fizyczny: p.659-672,fig.

Twórcy

autor

Zhang Z.

• Purdue University, West Lafayette, IN 47907-1393, USA

autor

Ostanin K.

autor

Van Etten R.L.

Bibliografia

• Bivin, D.B., Kubota, S., Pearlstein, R. & Morales, M.F. (1993) On how a myosin tryptophan may be perturbed. Proc. Natl. Acad. Sci. U.S.A. 90, 6791-6795.
• Black, M.J. & Joncs, M.E. (1983) Inorganic phos­phate determination in the presence of a labile organic phosphate: Assay for carbamyl phosphate phosphatase activity. Anal. Bio- chem. 135, 233-238.
• Bodansky, O. (1972) Acid phosphatases. Adv. Clin. Chem. 15, 43-147.
• Botts, J., Thomason, J.F. & Morales, M.F. (1989) On the origin and transmission of force in actomyosin subfragment-1. Proc. Natl. Acad. Sci. U.S.A. 86, 2204-2208.
• Bradford, M. (1976) Rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
• Buchwald, S., Saini, M.S., Knowles, J.R. & Van Etten, R.L. (1984) The stereochemical course of phospho-group transfer by human prostatic acid phosphatase. J. Biol. Chem. 259, 2208- 2213.
• Chen, S., Qiu, W. & Zheng, Y. (1993) Chemical modification of tryptophan residues of acid phosphatase from Branchiostoma helcheri. J. Xiamen University (Nat. Sci.) 32, 225-229.
• Crans, D.C., Simone, C.M., Saha, A.K. & Glew, R.H. (1989) Vanadate monomers and dimers both inhibit human prostatic acid phos­phatase. Biochem. Biophys. Res. Commun. 165, 246-250.
• Divita, G., Jault, J.-M., Gautheron, D.C. & Pietro, A.D. (1993) Chemical modification of p- subunit tryptophan residues in SchLzosac- charomyces pombe mitochondrial F1 adeno­sine 5'-triphosphatase: Differential reactivity and role in activity. Biochemistry 32, 1017- 1024.
• Fothergill-Gilmore, L. & Watson, H.C. (1988) The phosphoglycerate mutases Adv. Enzymol. 62, 227-313.
• Hsieh, P.-C., Shenoy, B.C., Haase, F.C., Jentoft, J.E. & Phillips, F.B. (1993) Involvement of tryptophan at the active site of polyphos­phate/ATP glucokinase from Mycobacterium tuberculosis. Biochemistry 32, 6243-6249.
• Inoue, M., Yamada, H., Yasukochi, T., Kuroki, R., Miki, T., Horiuchi, T. & Imoto, T. (1992) Mul­tiple role of hydrophobicity of tryptophan-108 in chicken lysozyme. Structural stability, sac­charide binding ability and abnormal p/sfa of glutamic acid-35. Biochemistry 31, 5445- 5553.
• Jackson, S.E., Moracci, M., Elmasry, N., Johnson, C.M. & Fersht, A.R. (1993) Effect of cavity- creating mutations in the hydrophobic core of chymotrypsin inhibitor 2. Biochemistry 32,11260-11269.
• Johnson, W.C., Bivin, D.B., Ue, K. & Morales, M.F. (1991) A search for protein structural changes accompanying the contractile inter­action. Proc. Natl. Acad. Sci. U.S.A. 88, 9748- 9750.
• Knighton, K.R., Pearson, R.B., Sowadski, J.M., Means, A.R., Ten Eyck, L.F., Taylor, S.S. & Kemp, B.E. (1992) Structural basis of the intrasteric regulation of myosin light chain kinases. Science 258, 130-135.
• Kunkel, T.A. (1985) Rapid and efficient site-spe­cific mutagenesis without phenotypic selec­tion. Proc. Natl. Acad. Sci. U.S.A. 82, 488- 492.
• Loewenthal, R., Sancho, J. & Fersht, A.R. (1992) Histidine-aromatic interactions in barnase. Elevation of histidine pKa and contribution to protein stability. J. Mol. Biol. 224, 759-770.
• Lundblad, R.L. ( 1991 ) Chemical Reagents for Pro­tein Modification-, 2nd edn., CRO Press, Boca Raton, FL.
• Lundblad, R.L. & Noyes, C.M. (1984) Chemical modification of tryptophan; in Chemical Re­agents for Protein Modification (Lundblad, R.L. & Noyes, C.M., eds.) pp. 47-71, CRC Press, Boca Raton, FL.
• McTigue, J.J. & Van Etten, R.L. (1978) An essen­tial active-site histidine residue in human prostatic acid phosphatase: Ethoxyformyla- tion by diethylpyrocarbonate and phosphory­lation by substrate. Biochim. Biophys. Acta 523, 407—421.
• Moller, K. & Van Etten, R.L. (1997) EXAFS Ana­lysis of the active site of the nonmetallo- enzyme human prostatic acid phosphatase by means of Cu2+ inactivation. Biospectroscopy 3, 85-%.
• Ostanin, K., Harms, E., Stevis, P., Kuciel, R., Zhou, M.-M. & Van Etten, R.L. (1992) Over- expression, site-directed mutagenesis and catalytic mechanism of E. coli acid phos­phatase. J. Biol. Chem. 267, 22830-22836.
• Ostanin, K., Saeed, A. & Van Etten, R.L. (1994) Heterologous expression of human prostatic acid phosphatase and site-directed mutagene- sis of the enzyme active site. J. Biol. Chem. 269, 8971-8978.
• Ostrowski, W. (1978) Isolation or x-phosphohis- tidine from a phosphoryl-enzyme intermedi­ate of human prostatic acid phosphatase. Bio­chim. Biophys. Acta 526, 147-153.
• Ostrowski, W. (1980) Prostatic phosphatase; in Male Accessory Sex Glands (Spring-Mills, E. & Hafez, E., eds) pp. 197-213, Elsevier/North Holland, Amsterdam.
• Ostrowski, W. & Barnard, E.A. (1973) Evidence for a phosphoryl-enzyme intermediate in the catalytic reaction of prostatic acid phos­phatase. Biochemistry 12, 3893-3898.
• Pace, C.N., Shirley, B.A. & Thomson, J.A. (1989) Measuring the conformational stability of a protein; in Protein Structure, a Practical Approach (Creighton, T.E., ed.) pp. 311-329, IRL Press, Eynsham, Oxford.
• Rybarska, J. & Ostrowski, W. (1974) Acid phos­phatase from human prostate. Chemical modification and activity of the enzyme Acta Biochim. Polon. 21, 377-390.
• Saini, M.S. & Van Etten, R.L. (1979) Essential carboxylic acid groups in human prostatic acid phosphatase. Biochim. Biophys. Acta 568, 370-376.
• Sampson, N.S. & Knowles, J.R. (1992) Segmental movement: Definition of the structural re­quirements for loop closure in catalysis by triosephosphate isomerase. Biochemistry 31, 8482-8487.
• Schneider, G., Lindqvist, Y. & Vihko, P. (1993) Three-dimensional structure of rat acid phos­phatase. EMBO J. 12, 2609-2615.
• Scoflone, E., Fontana, A. & Rocchi, R. (1968) Sulfenyl halides as modifying reagents for polypeptides and proteins. I. Modification of tryptophan residues. Biochemistry 7, 971- 979.
• Smith, J.K. & Whitby, L.G. (1968) The heteroge­neity of prostatic acid phosphatase. Biochim. Biophys. Acta 151, 607-618.
• Steczko, J., Hermodson, M., Axelrod, B. & Dziem- bor-Kentzer, E. (1983) Identification of the target amino acids in the site-specific inacti­vation of triosephosphate isomerase by fer­rate ion. J. Biol. Chem. 258, 13148-13154.
• Van Etten, R.L. (1982) Human prostatic acid phosphatase: A histidine phosphatase. Ann. N.Y. Acad. Sci. 390, 27-51.
• Van Etten, R.L & McTigue, J.J. (1977) pH de­pendence and solvent isotope effects in the hydrolysis of phosphomonoesters by human prostatic acid phosphatase. Biochim. Bio- phys. Ada 484, 386-397.
• Van Etten, R.L. & Saini. M.S. (1978) Selective purification of tartrate-inhibitable acid phos­phatases: Rapid and efficient purification (to homogeneity) of human and canine prostatic acid phosphatases. Clin. Chem. 24, 1525— 1530.
• Van Etten, R.L., Davidson, R.. Stevis, P., Mac- Arthur, H. & Moore, D. (1991) Covalent struc­ture, disulfide bonding and identification of reactive surface and active site residues of human prostatic acid phosphatase. . Biol. Chem. 266, 2313-2319.